Olympus Launches New Surgical Energy Device for Hemostatic Cutting and Vessel Sealing Olympus Oct 21, 2025 22:00 HKT/SGT Read More
Indonesia's Legacy in the Global Vaccine Landscape: Bio Farma and DCVMN Strengthen Health Resilience through Global Partnership PT Bio Farma (Persero) Oct 21, 2025 15:45 HKT/SGT Read More
Olympus: "Feasibility study on the development of Japanese digitalized endoscopy infection control systems in India" Selected for METI's FY2024 Supplementary "Global South Future-Oriented Co-Creation Subsidy Program (Small-Scale Demonstration / Feasibility Study Project)" Olympus Oct 21, 2025 10:00 HKT/SGT Read More
LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025" Eisai Oct 14, 2025 16:54 HKT/SGT Read More
Eisai and Biogen Announce U.S. Availability of LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer's Disease Eisai Oct 08, 2025 11:03 HKT/SGT Read More
Olympus Launches SecureFlex, a Single-use Fine Needle Biopsy Device Olympus Oct 06, 2025 14:00 HKT/SGT Read More
Eisai Highlights Breadth of Oncology Research at ESMO 2025 Eisai Oct 03, 2025 17:01 HKT/SGT Read More
DOCOMO and PaMeLa Develop World's First Technology to Share Pain Perception Tailored to Individual Sensitivity NTT DOCOMO Oct 01, 2025 21:18 HKT/SGT Read More
The Second Proton Therapy System Begins Treatment at University of Tsukuba Hospital Hitachi, Ltd. Oct 01, 2025 19:37 HKT/SGT Read More
Olympus Commits to Advancing Sustainable Packaging Enabled by DuPont(TM) Tyvek(R) with Renewable Attribution Olympus Sep 30, 2025 12:00 HKT/SGT Read More
"LEQEMBI(R)" (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease Approved in China Eisai Sep 29, 2025 09:33 HKT/SGT Read More
China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication China Medical System Holdings Limited Sep 28, 2025 16:00 JST Read More
Entered a partnership with ELITech in the Field of Molecular Testing for Infectious Disease Hitachi, Ltd. Sep 25, 2025 18:01 HKT/SGT Read More
LEQEMBI(R) (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Australia Eisai Sep 24, 2025 18:04 HKT/SGT Read More
China Medical System (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies China Medical System Holdings Limited Sep 23, 2025 13:15 JST Read More
Counterfeit Products Sold Online in Malaysia Threaten Halal Compliance, Consumer Health, and the E-Commerce Sector, Says Muslim Consumers Association (PPIM) Persatuan Pengguna Islam Malaysia (PPIM) Sep 22, 2025 04:54 JST Read More
EASD 2025 | HighTide Therapeutics Announces Oral Presentation of Phase 3 Data in Patients with Type 2 Diabetes HighTide Therapeutics Inc. Sep 17, 2025 08:00 HKT/SGT Read More
"New Answers to Dementia" Eisai Releases Concept Movie and New Content on Campaign Website for Dementia Month Eisai Sep 12, 2025 12:20 HKT/SGT Read More
